• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tau seeds are subject to aberrant modifications resulting in distinct signatures.tau 种子会发生异常修饰,从而产生独特的特征。
Cell Rep. 2021 Apr 27;35(4):109037. doi: 10.1016/j.celrep.2021.109037.
2
Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer's disease.新型抗乙酰化tau 单克隆抗体的研制及其在阿尔茨海默病中探测致病tau 种的特性。
Acta Neuropathol Commun. 2024 Oct 12;12(1):163. doi: 10.1186/s40478-024-01865-1.
3
Essential tremor with tau pathology features seeds indistinguishable in conformation from Alzheimer's disease and primary age-related tauopathy.具有tau病理特征的特发性震颤的种子在构象上与阿尔茨海默病和原发性年龄相关tau病难以区分。
Acta Neuropathol. 2025 Jan 8;149(1):6. doi: 10.1007/s00401-024-02843-6.
4
Polyamination with spermidine enhances pathogenic tau conformations while reducing filamentous aggregate formation in vitro.用亚精胺进行多胺化反应可增强致病性tau构象,同时在体外减少丝状聚集体的形成。
Biochem J. 2025 Jun 17;482(12):877-99. doi: 10.1042/BCJ20253079.
5
Establishment of a high-content imaging assay for tau aggregation in hiPSC-derived neurons differentiated from two protocols to routinely evaluate compounds and genetic perturbations.建立一种高内涵成像分析方法,用于检测从两种方案分化而来的人诱导多能干细胞衍生神经元中的tau聚集,以常规评估化合物和基因扰动。
SLAS Discov. 2024 Mar;29(2):100137. doi: 10.1016/j.slasd.2023.12.009. Epub 2023 Dec 19.
6
The Role and Pathogenesis of Tau Protein in Alzheimer's Disease.Tau蛋白在阿尔茨海默病中的作用及发病机制
Biomolecules. 2025 Jun 5;15(6):824. doi: 10.3390/biom15060824.
7
Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies.分泌颗粒素-1 是一种新型的磷酸化 tau 结合蛋白,它在阿尔茨海默病中积累,而不在其他 tau 病中积累。
Acta Neuropathol Commun. 2019 Dec 3;7(1):195. doi: 10.1186/s40478-019-0848-6.
8
The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system.嗅觉上皮:病理性tau蛋白传播的关键通道及减轻中枢神经系统tau蛋白病的靶点。
Acta Neuropathol. 2025 Jun 19;149(1):64. doi: 10.1007/s00401-025-02902-6.
9
Acute targeting of N-terminal tau protein has long-lasting beneficial effects in Tg2576 APP/Aβ mouse model by reducing cognitive impairment, cerebral Aβ-amyloidosis, synaptic remodeling and microgliosis later in life.在Tg2576 APP/Aβ小鼠模型中,对N端tau蛋白进行急性靶向作用可通过减轻晚年的认知障碍、脑Aβ淀粉样变性、突触重塑和小胶质细胞增生,产生长期有益影响。
Acta Neuropathol Commun. 2025 May 29;13(1):121. doi: 10.1186/s40478-025-02022-y.
10
Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer's disease: implications for biomarker development and therapeutic targeting.探讨半胱氨酸天冬氨酸蛋白酶切割的 tau 在 tau 病中的意义以及作为阿尔茨海默病中磷酸化 tau 的互补病理学:对生物标志物开发和治疗靶点的影响。
Acta Neuropathol Commun. 2024 Feb 28;12(1):36. doi: 10.1186/s40478-024-01744-9.

引用本文的文献

1
Cytoskeletal Proteins and Alzheimer's Disease Pathogenesis: Focusing on the Interplay with Tau Pathology.细胞骨架蛋白与阿尔茨海默病发病机制:聚焦于与tau病理的相互作用
Biomolecules. 2025 Jun 6;15(6):831. doi: 10.3390/biom15060831.
2
Upregulation of ISG15 induced by MAPT/tau accumulation represses autophagic flux by inhibiting HDAC6 activity: a vicious cycle in Alzheimer disease.由MAPT/tau蛋白积累诱导的ISG15上调通过抑制HDAC6活性来抑制自噬流:阿尔茨海默病中的恶性循环。
Autophagy. 2025 Apr;21(4):807-826. doi: 10.1080/15548627.2024.2431472. Epub 2024 Dec 24.
3
From Fundamentals to Innovation in Alzheimer's Disease: Molecular Findings and Revolutionary Therapies.从阿尔茨海默病的基础到创新:分子发现和革命性疗法。
Int J Mol Sci. 2024 Nov 16;25(22):12311. doi: 10.3390/ijms252212311.
4
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.阿尔茨海默病的最新研究进展:从基础研究到诊断和治疗。
Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x.
5
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies.tau 蛋白在神经退行性疾病中的作用:分子机制、生物标志物和治疗策略。
Transl Neurodegener. 2024 Aug 6;13(1):40. doi: 10.1186/s40035-024-00429-6.
6
PTPRS is a novel marker for early Tau pathology and synaptic integrity in Alzheimer's disease.PTPRS 是阿尔茨海默病中早期 Tau 病理学和突触完整性的新型标志物。
Sci Rep. 2024 Jun 26;14(1):14718. doi: 10.1038/s41598-024-65104-2.
7
Hyperacetylation mimetics within the tau filament core inhibits prion-like propagation of misfolded tau.tau蛋白细丝核心内的超乙酰化模拟物可抑制错误折叠的tau蛋白的朊病毒样传播。
bioRxiv. 2024 Apr 15:2024.04.12.589253. doi: 10.1101/2024.04.12.589253.
8
Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein.采用重组蛋白的生物化学方法评估翻译后修饰对致病性 tau 构象的影响。
Biochem Soc Trans. 2024 Feb 28;52(1):301-318. doi: 10.1042/BST20230596.
9
The emerging nontraditional roles for tau in the brain.tau蛋白在大脑中新兴的非传统作用。
Cytoskeleton (Hoboken). 2024 Jan;81(1):89-94. doi: 10.1002/cm.21811. Epub 2023 Dec 8.
10
Distinct tau folds initiate templated seeding and alter the post-translational modification profile.不同的 tau 构象启动模板化的种子形成,并改变翻译后修饰谱。
Brain. 2023 Dec 1;146(12):4988-4999. doi: 10.1093/brain/awad272.

本文引用的文献

1
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease.tau 修饰谱可识别患者异质性和阿尔茨海默病的阶段。
Cell. 2020 Dec 10;183(6):1699-1713.e13. doi: 10.1016/j.cell.2020.10.029. Epub 2020 Nov 13.
2
An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline.一种依赖于组蛋白去乙酰化酶 6 的监控机制可以抑制 tau 介导的神经退行性病变和认知能力下降。
Nat Commun. 2020 Nov 2;11(1):5522. doi: 10.1038/s41467-020-19317-4.
3
ASK1-Mediated Phosphorylation Blocks HDAC6 Ubiquitination and Degradation to Drive the Disassembly of Photoreceptor Connecting Cilia.ASK1 介导的磷酸化阻止 HDAC6 的泛素化和降解,从而驱动光感受器连接纤毛的解体。
Dev Cell. 2020 May 4;53(3):287-299.e5. doi: 10.1016/j.devcel.2020.03.010. Epub 2020 Apr 9.
4
Tau Reduction Prevents Key Features of Autism in Mouse Models.tau 蛋白减少可预防自闭症模型中的关键特征。
Neuron. 2020 May 6;106(3):421-437.e11. doi: 10.1016/j.neuron.2020.01.038. Epub 2020 Mar 2.
5
Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains.翻译后修饰介导了tau蛋白病毒株的结构多样性。
Cell. 2020 Feb 20;180(4):633-644.e12. doi: 10.1016/j.cell.2020.01.027. Epub 2020 Feb 6.
6
Site-Specific Hyperphosphorylation Inhibits, Rather than Promotes, Tau Fibrillization, Seeding Capacity, and Its Microtubule Binding.位点特异性过度磷酸化抑制而非促进 Tau 纤维形成、成核能力及其微管结合。
Angew Chem Int Ed Engl. 2020 Mar 2;59(10):4059-4067. doi: 10.1002/anie.201913001. Epub 2020 Jan 28.
7
Introduction of Tau Oligomers into Cortical Neurons Alters Action Potential Dynamics and Disrupts Synaptic Transmission and Plasticity.tau 寡聚物进入皮质神经元会改变动作电位动力学,并破坏突触传递和可塑性。
eNeuro. 2019 Oct 15;6(5). doi: 10.1523/ENEURO.0166-19.2019. Print 2019 Sep/Oct.
8
Interactive Peptide Spectral Annotator: A Versatile Web-based Tool for Proteomic Applications.交互式肽谱注释器:一种用于蛋白质组学应用的多功能网络工具。
Mol Cell Proteomics. 2019 Aug 9;18(8 suppl 1):S193-S201. doi: 10.1074/mcp.TIR118.001209. Epub 2019 May 14.
9
ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome-lysosome fusion.ATP13A2 将 HDAC6 募集到溶酶体以促进自噬体-溶酶体融合。
J Cell Biol. 2019 Jan 7;218(1):267-284. doi: 10.1083/jcb.201804165. Epub 2018 Dec 11.
10
Tau monomer encodes strains.tau 单体编码菌株。
Elife. 2018 Dec 11;7:e37813. doi: 10.7554/eLife.37813.

tau 种子会发生异常修饰,从而产生独特的特征。

Tau seeds are subject to aberrant modifications resulting in distinct signatures.

机构信息

Department of Neurology and the UNC Neuroscience Center, University of North Carolina, Chapel Hill, NC 27599, USA.

UNC Proteomics Core Facility, Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599, USA.

出版信息

Cell Rep. 2021 Apr 27;35(4):109037. doi: 10.1016/j.celrep.2021.109037.

DOI:10.1016/j.celrep.2021.109037
PMID:33910013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8135111/
Abstract

The prion-like spread of tau pathology could underlie a spectrum of clinical syndromes including Alzheimer's disease (AD). Although evidence indicates that tau is transmissible, it is unclear how pathogenic tau seeds are processed in neurons. Here, we analyze fibrillar wild-type and disease-associated P301L tau seeds by using in vitro and neuronal assays. We show that P301L seeds are uniquely modified by post-translational modifications (PTMs) within the microtubule-binding region (MTBR). Although these modifications do not alter tau seed trafficking or localization, acetylated tau variants show accelerated tau aggregation, enhanced tau PTM priming, and prion-like templating. To explain the enhanced tau seed acetylation, we demonstrate that P301L seeds undergo auto-acetylation. Moreover, tau acts generally to inhibit HDAC6 deacetylase activity by preventing HDAC6 phosphorylation, leading to increased substrate acetylation. Our study highlights complex post-translational regulation of transmissible tau seeds and provides insight into the biological properties of tau strains in AD and other tauopathies.

摘要

tau 病理的类朊病毒传播可能是包括阿尔茨海默病(AD)在内的一系列临床综合征的基础。尽管有证据表明 tau 是可传播的,但尚不清楚致病性 tau 种子在神经元中是如何被加工的。在这里,我们通过体外和神经元测定分析了纤维状野生型和与疾病相关的 P301L tau 种子。我们表明,P301L 种子在微管结合区(MTBR)内被独特的翻译后修饰(PTMs)修饰。尽管这些修饰不会改变 tau 种子的运输或定位,但乙酰化 tau 变体显示出加速的 tau 聚集、增强的 tau PTM 引发和类朊病毒模板。为了解释增强的 tau 种子乙酰化,我们证明 P301L 种子发生自身乙酰化。此外,tau 通过防止 HDAC6 磷酸化通常起抑制 HDAC6 脱乙酰酶活性的作用,导致底物乙酰化增加。我们的研究强调了可传播 tau 种子的复杂翻译后调节,并深入了解 AD 和其他 tau 病中 tau 菌株的生物学特性。